Lys34

Site Information
IERIKVSkASADLMs SwissProt Entrez-Gene
Blast this site against: NCBI SwissProt PDB
Site Group ID: 3934264

In vivo Characterization
Methods used to characterize site in vivo:	mass spectrometry ( 1 , 2 , 3 , 4 , 5 , 6 , 7 , 8 , 9 , 10 , 11 , 12 , 13 , 14 , 15 )
Relevant cell line - cell type - tissue:	'brain, embryonic' ( 14 ) , brain ( 1 , 15 ) , heart ( 1 ) , kidney ( 1 ) , liver ( 1 , 13 ) , pooled tissues ( 1 ) , spleen ( 2 ) , testis ( 3 )

References
1	Wagner SA, et al. (2012) Proteomic analyses reveal divergent ubiquitylation site patterns in murine tissues. Mol Cell Proteomics 11, 1578-85 22790023 Curated Info
2	Guo A (2009) CST Curation Set: 8159; Year: 2009; Biosample/Treatment: tissue, spleen/untreated; Disease: -; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: Ub(K-e-GG) Antibodies Used to Purify Peptides prior to LCMS: Ubiquitin (D4A7A10) XP(R) Rabbit mAb Cat#: 3925, PTMScan(R) Ubiquitin Branch Motif (K-e-GG) Immunoaffinity Beads Cat#: 1990 Curated Info
3	Guo A (2009) CST Curation Set: 8160; Year: 2009; Biosample/Treatment: tissue, testis/untreated; Disease: -; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: Ub(K-e-GG) Antibodies Used to Purify Peptides prior to LCMS: Ubiquitin (D4A7A10) XP(R) Rabbit mAb Cat#: 3925, PTMScan(R) Ubiquitin Branch Motif (K-e-GG) Immunoaffinity Beads Cat#: 1990 Curated Info
4	Guo A (2008) CST Curation Set: 4120; Year: 2008; Biosample/Treatment: tissue, brain/untreated; Disease: Alzheimer's disease; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: Ub(K-e-GG) Curated Info
5	Guo A (2008) CST Curation Set: 4121; Year: 2008; Biosample/Treatment: tissue, brain/untreated; Disease: Alzheimer's disease; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: Ub(K-e-GG) Curated Info
6	Guo A (2008) CST Curation Set: 4122; Year: 2008; Biosample/Treatment: tissue, brain/untreated; Disease: Alzheimer's disease; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: Ub(K-e-GG) Curated Info
7	Guo A (2008) CST Curation Set: 4123; Year: 2008; Biosample/Treatment: tissue, brain/untreated; Disease: Alzheimer's disease; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: Ub(K-e-GG) Curated Info
8	Guo A (2008) CST Curation Set: 4124; Year: 2008; Biosample/Treatment: tissue, brain/untreated; Disease: Alzheimer's disease; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: Ub(K-e-GG) Curated Info
9	Guo A (2008) CST Curation Set: 4125; Year: 2008; Biosample/Treatment: tissue, brain/untreated; Disease: Alzheimer's disease; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: Ub(K-e-GG) Curated Info
10	Guo A (2008) CST Curation Set: 4126; Year: 2008; Biosample/Treatment: tissue, brain/untreated; Disease: Alzheimer's disease; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: Ub(K-e-GG) Curated Info
11	Guo A (2008) CST Curation Set: 4127; Year: 2008; Biosample/Treatment: tissue, brain/untreated; Disease: Alzheimer's disease; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: Ub(K-e-GG) Curated Info
12	Guo A (2008) CST Curation Set: 4129; Year: 2008; Biosample/Treatment: tissue, brain/untreated; Disease: Alzheimer's disease; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: Ub(K-e-GG) Curated Info
13	Guo A (2007) CST Curation Set: 3115; Year: 2007; Biosample/Treatment: tissue, liver/-; Disease: -; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: Ub(K-e-GG) Curated Info
14	Guo A (2007) CST Curation Set: 3116; Year: 2007; Biosample/Treatment: tissue, brain, embryonic/-; Disease: -; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: Ub(K-e-GG) Curated Info
15	Guo A (2007) CST Curation Set: 3117; Year: 2007; Biosample/Treatment: tissue, brain/-; Disease: -; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: Ub(K-e-GG) Curated Info